Assenagon Asset Management S.A. boosted its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 114.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 512,970 shares of the company's stock after buying an additional 273,357 shares during the quarter. Assenagon Asset Management S.A. owned 0.25% of Docusign worth $39,955,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in DOCU. New Age Alpha Advisors LLC grew its position in Docusign by 738.2% during the 1st quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock worth $3,353,000 after purchasing an additional 36,273 shares in the last quarter. Pinpoint Asset Management Ltd grew its position in Docusign by 54.3% during the 1st quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock worth $4,639,000 after purchasing an additional 20,043 shares in the last quarter. Concurrent Investment Advisors LLC purchased a new position in Docusign during the 1st quarter worth approximately $618,000. Gilman Hill Asset Management LLC grew its position in Docusign by 4.9% during the 1st quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company's stock worth $6,864,000 after purchasing an additional 3,904 shares in the last quarter. Finally, Blair William & Co. IL grew its position in Docusign by 1.7% during the 1st quarter. Blair William & Co. IL now owns 387,542 shares of the company's stock worth $31,546,000 after purchasing an additional 6,460 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.
Insider Activity
In other news, Director Peter Solvik sold 15,000 shares of the business's stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the transaction, the director owned 135,253 shares in the company, valued at approximately $11,020,414.44. The trade was a 9.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Anna Marrs sold 728 shares of the business's stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $80.30, for a total transaction of $58,458.40. Following the transaction, the director owned 10,799 shares in the company, valued at approximately $867,159.70. The trade was a 6.32% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 82,533 shares of company stock worth $6,598,028. Insiders own 1.66% of the company's stock.
Docusign Trading Up 0.3%
Docusign stock traded up $0.27 on Monday, reaching $84.86. 1,935,665 shares of the stock were exchanged, compared to its average volume of 3,496,048. The stock has a market cap of $17.07 billion, a PE ratio of 63.80, a PEG ratio of 4.43 and a beta of 1.02. Docusign Inc. has a twelve month low of $58.00 and a twelve month high of $107.86. The firm has a fifty day moving average price of $76.56 and a two-hundred day moving average price of $79.31.
Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business's revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.
Docusign declared that its board has initiated a stock repurchase program on Thursday, June 5th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board believes its stock is undervalued.
Analyst Ratings Changes
A number of equities research analysts have issued reports on DOCU shares. JMP Securities reissued a "market outperform" rating and set a $124.00 target price on shares of Docusign in a research note on Friday, September 5th. Royal Bank Of Canada lifted their target price on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research note on Friday, September 5th. Morgan Stanley lifted their target price on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday, September 8th. Citigroup lifted their target price on shares of Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, September 4th. Finally, Piper Sandler lifted their target price on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $94.14.
Get Our Latest Report on Docusign
Docusign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.